Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 989 GBX 0.05% Market Closed
Market Cap: 4.4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Income Statement

Earnings Waterfall
Hikma Pharmaceuticals PLC

Revenue
3B USD
Cost of Revenue
-1.6B USD
Gross Profit
1.4B USD
Operating Expenses
-813m USD
Operating Income
617m USD
Other Expenses
-332m USD
Net Income
285m USD

Income Statement
Hikma Pharmaceuticals PLC

Rotate your device to view
Income Statement
Currency: USD
Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
262
N/A
285
+9%
317
+11%
387
+22%
449
+16%
524
+17%
581
+11%
602
+4%
637
+6%
673
+6%
731
+9%
768
+5%
918
+20%
1 056
+15%
1 109
+5%
1 215
+10%
1 365
+12%
1 465
+7%
1 489
+2%
1 460
-2%
1 440
-1%
1 613
+12%
1 950
+21%
1 963
+1%
1 936
-1%
2 020
+4%
2 076
+3%
2 130
+3%
2 203
+3%
2 292
+4%
2 341
+2%
2 425
+4%
2 553
+5%
2 550
0%
2 517
-1%
2 731
+9%
2 875
+5%
3 017
+5%
Gross Profit
Cost of Revenue
(126)
(142)
(158)
(195)
(227)
(281)
(324)
(330)
(332)
(341)
(374)
(417)
(523)
(599)
(605)
(592)
(601)
(613)
(638)
(650)
(622)
(746)
(932)
(938)
(963)
(1 008)
(1 004)
(1 019)
(1 108)
(1 139)
(1 128)
(1 198)
(1 252)
(1 242)
(1 252)
(1 356)
(1 468)
(1 587)
Gross Profit
136
N/A
143
+5%
159
+11%
193
+21%
222
+15%
243
+10%
257
+6%
273
+6%
304
+12%
332
+9%
357
+8%
351
-2%
395
+12%
457
+16%
504
+10%
623
+24%
764
+23%
852
+11%
851
0%
810
-5%
818
+1%
867
+6%
1 018
+17%
1 025
+1%
973
-5%
1 012
+4%
1 072
+6%
1 111
+4%
1 095
-1%
1 153
+5%
1 213
+5%
1 227
+1%
1 301
+6%
1 308
+1%
1 265
-3%
1 375
+9%
1 407
+2%
1 430
+2%
Operating Income
Operating Expenses
(68)
(74)
(84)
(107)
(129)
(149)
(169)
(182)
(197)
(207)
(222)
(242)
(277)
(312)
(337)
(387)
(412)
(408)
(449)
(450)
(437)
(504)
(599)
(606)
(587)
(588)
(623)
(647)
(621)
(647)
(687)
(682)
(742)
(773)
(756)
(760)
(785)
(813)
Selling, General & Administrative
(50)
(54)
(65)
(88)
(107)
(121)
(134)
(144)
(157)
(172)
(191)
(203)
(233)
(261)
(273)
(288)
(311)
(335)
(356)
(355)
(372)
(388)
(392)
(407)
(426)
(437)
(437)
(434)
(453)
(466)
(464)
(467)
(488)
(512)
(509)
(513)
(544)
(564)
Research & Development
(17)
(18)
(18)
(19)
(19)
(21)
(22)
(19)
(17)
(19)
(24)
(25)
(31)
(37)
(34)
(36)
(39)
(39)
(55)
(56)
(36)
(73)
(126)
(129)
(115)
(102)
(118)
(129)
(126)
(130)
(137)
(134)
(143)
(153)
(144)
(139)
(149)
(146)
Depreciation & Amortization
0
0
0
0
0
(4)
(7)
(7)
(7)
(7)
(7)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(17)
(34)
(38)
(42)
(50)
(73)
(87)
(92)
(92)
(88)
(90)
Other Operating Expenses
(2)
(2)
(1)
(1)
(3)
(3)
(6)
(11)
(16)
(9)
0
(13)
(13)
(15)
(30)
(63)
(62)
(35)
(38)
(39)
(29)
(43)
(81)
(70)
(46)
(49)
(68)
(67)
(8)
(13)
(44)
(31)
(38)
(21)
(11)
(16)
(4)
(13)
Operating Income
68
N/A
69
+1%
74
+8%
85
+15%
92
+8%
94
+1%
87
-7%
91
+5%
107
+18%
124
+16%
135
+9%
110
-19%
119
+8%
145
+22%
167
+15%
236
+41%
352
+49%
444
+26%
402
-9%
360
-10%
381
+6%
363
-5%
419
+15%
419
N/A
386
-8%
424
+10%
449
+6%
464
+3%
474
+2%
506
+7%
526
+4%
545
+4%
559
+3%
535
-4%
509
-5%
615
+21%
622
+1%
617
-1%
Pre-Tax Income
Interest Income Expense
(2)
0
1
(3)
(9)
(15)
(17)
(15)
(12)
(12)
(14)
(16)
(24)
(31)
(37)
(37)
(36)
(34)
(16)
(41)
(40)
(61)
(39)
(9)
43
17
(39)
(35)
(27)
(41)
(33)
(49)
(41)
(64)
(65)
(83)
(67)
(79)
Non-Reccuring Items
0
0
0
0
0
(6)
(6)
(0)
0
0
0
0
0
0
1
(14)
(19)
(6)
(6)
(6)
(9)
(71)
(158)
(171)
(1 159)
(1 130)
(104)
(38)
60
74
76
107
39
(31)
(200)
(312)
(260)
(171)
Total Other Income
(1)
(1)
0
0
0
0
0
(0)
(0)
(1)
(1)
0
(1)
(1)
1
1
1
1
(18)
0
(14)
0
(12)
(12)
(8)
(8)
(13)
(13)
(16)
0
(11)
0
(13)
0
(11)
0
(14)
0
Pre-Tax Income
64
N/A
68
+6%
76
+11%
83
+9%
84
+1%
74
-12%
64
-13%
75
+17%
95
+26%
112
+18%
121
+8%
93
-23%
94
+1%
112
+19%
132
+18%
186
+41%
298
+60%
405
+36%
362
-11%
313
-14%
318
+2%
231
-27%
210
-9%
227
+8%
(738)
N/A
(697)
+6%
293
N/A
378
+29%
491
+30%
539
+10%
558
+4%
603
+8%
544
-10%
440
-19%
233
-47%
220
-6%
281
+28%
367
+31%
Net Income
Tax Provision
(19)
(18)
(20)
(21)
(20)
(13)
(7)
(8)
(16)
(22)
(22)
(13)
(11)
(21)
(25)
(45)
(82)
(95)
(80)
(67)
(64)
(53)
(52)
(58)
(150)
(152)
(8)
(17)
(4)
(25)
(128)
(137)
(124)
(94)
(42)
(72)
(89)
(77)
Income from Continuing Operations
45
50
56
62
64
61
57
68
79
90
100
80
84
91
107
141
216
311
282
246
254
178
158
169
(888)
(849)
285
361
487
514
430
466
420
346
191
148
192
290
Income to Minority Interest
(1)
(1)
(2)
(2)
(2)
(1)
0
(0)
(2)
(1)
(1)
(3)
(3)
(4)
(7)
(7)
(4)
(3)
(4)
(3)
(2)
(2)
(3)
(3)
(4)
(6)
(3)
0
(1)
(1)
1
1
1
0
(3)
(2)
(2)
(5)
Net Income (Common)
44
N/A
49
+11%
55
+11%
60
+10%
63
+4%
60
-4%
57
-5%
67
+18%
78
+15%
89
+15%
99
+11%
77
-22%
80
+4%
87
+9%
100
+14%
133
+33%
212
+59%
307
+45%
278
-10%
243
-13%
252
+4%
176
-30%
155
-12%
166
+7%
(843)
N/A
(806)
+4%
282
N/A
361
+28%
486
+35%
513
+6%
431
-16%
467
+8%
421
-10%
346
-18%
188
-46%
146
-22%
190
+30%
285
+50%
EPS (Diluted)
0.29
N/A
0.29
N/A
0.31
+7%
0.34
+10%
0.35
+3%
0.32
-9%
0.3
-6%
0.35
+17%
0.4
+14%
0.46
+15%
0.51
+11%
0.4
-22%
0.41
+2%
0.44
+7%
0.5
+14%
0.67
+34%
1.07
+60%
1.55
+45%
1.39
-10%
1.22
-12%
1.25
+2%
0.77
-38%
0.66
-14%
0.69
+5%
-3.51
N/A
-3.33
+5%
1.17
N/A
1.49
+27%
2
+34%
2.11
+5%
1.81
-14%
2.01
+11%
1.81
-10%
1.5
-17%
0.84
-44%
0.66
-21%
0.85
+29%
1.27
+49%

See Also

Discover More